China International Capital Corporation

Ares Capital Corporation Announces Public Offering

Retrieved on: 
Monday, November 7, 2022

Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 8,000,000 shares of its common stock.

Key Points: 
  • Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 8,000,000 shares of its common stock.
  • Ares Capital expects to use the net proceeds of this offering to repay certain outstanding indebtedness under its debt facilities.
  • Ares Capital believes its loans and other investments in these companies can generate attractive levels of current income and potential capital appreciation for investors.
  • Ares Capital is externally managed by a subsidiary of Ares Management Corporation (NYSE: ARES), a publicly traded, leading global alternative investment manager.

Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call

Retrieved on: 
Monday, November 7, 2022

The Company also expects to issue its earnings press release on Wednesday, November 9, 2022 after the close of the markets.

Key Points: 
  • The Company also expects to issue its earnings press release on Wednesday, November 9, 2022 after the close of the markets.
  • The Company will host a conference call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time.
  • A replay of the audio webcast will be available on the Company's website for approximately 30 days following the conference call.
  • Prospect Capital Corporation ( www.prospectstreet.com ) is a business development company that focuses on lending to and investing in private businesses.

International Communication Forum: Towards a fairer, safer world

Retrieved on: 
Wednesday, November 2, 2022

HONG KONG, Nov. 2, 2022 /PRNewswire/ -- The International Communication Forum: Towards a fairer, safer world", jointly organized by Friday Culture Limited and the Hong Kong Coalition, was held on 2 November. The Forum was officiated by Mr John KC LEE, the Chief Executive of the Hong Kong Special Administrative Region; Ms LU Xinning, Deputy Director, Liaison Office of Central People's Government in the HKSAR; Mr YANG Yirui, Deputy Commissioner of the Ministry of Foreign Affairs of the People's Republic of China in the HKSAR; Mrs Regina IP, The Convenor of the Non-official Members of the Executive Council of the HKSAR; Dr Herman HU, Chairman, Friday Culture Limited; Dr Kennedy WONG, Vice Secretary-General, Hong Kong Coalition; Mr Patrick Tsang, Chief Executive Officer, Chow Tai Fook Enterprises Limited.

Key Points: 
  • HONG KONG, Nov. 2, 2022 /PRNewswire/ -- The International Communication Forum: Towards a fairer, safer world", jointly organized by Friday Culture Limited and the Hong Kong Coalition, was held on 2 November.
  • When we put our heads together, we are good at solving problems."
  • The forum included two panel discussions, the first panel discussed "Achieving fairness in a polarised world".
  • Founded in 2021, Friday Culture Limited is a multi-dimensional media company which celebrates cultural diversity, promotes peace and shares insight.

International Communication Forum: Towards a fairer, safer world

Retrieved on: 
Wednesday, November 2, 2022

HONG KONG, Nov. 2, 2022 /PRNewswire/ -- The International Communication Forum: Towards a fairer, safer world", jointly organized by Friday Culture Limited and the Hong Kong Coalition, was held on 2 November. The Forum was officiated by Mr John KC LEE, the Chief Executive of the Hong Kong Special Administrative Region; Ms LU Xinning, Deputy Director, Liaison Office of Central People's Government in the HKSAR; Mr YANG Yirui, Deputy Commissioner of the Ministry of Foreign Affairs of the People's Republic of China in the HKSAR; Mrs Regina IP, The Convenor of the Non-official Members of the Executive Council of the HKSAR; Dr Herman HU, Chairman, Friday Culture Limited; Dr Kennedy WONG, Vice Secretary-General, Hong Kong Coalition; Mr Patrick Tsang, Chief Executive Officer, Chow Tai Fook Enterprises Limited.

Key Points: 
  • HONG KONG, Nov. 2, 2022 /PRNewswire/ -- The International Communication Forum: Towards a fairer, safer world", jointly organized by Friday Culture Limited and the Hong Kong Coalition, was held on 2 November.
  • When we put our heads together, we are good at solving problems."
  • The forum included two panel discussions, the first panel discussed "Achieving fairness in a polarised world".
  • Founded in 2021, Friday Culture Limited is a multi-dimensional media company which celebrates cultural diversity, promotes peace and shares insight.

OFS Capital Corporation Announces Date for Its Third Quarter 2022 Earnings Release and Conference Call

Retrieved on: 
Monday, October 31, 2022

OFS Capital Corporation (NASDAQ: OFS) (OFS Capital), a business development company, announced today that, prior to the opening of the stock market on Friday, November 4, 2022, it will report its third quarter 2022 earnings results.

Key Points: 
  • OFS Capital Corporation (NASDAQ: OFS) (OFS Capital), a business development company, announced today that, prior to the opening of the stock market on Friday, November 4, 2022, it will report its third quarter 2022 earnings results.
  • A conference call is scheduled for later that day at 10:00 a.m. Eastern Time to discuss OFS Capitals financial results and business.
  • Bilal Rashid, Chairman & Chief Executive Officer, will host the call, along with Jeffrey Cerny, Chief Financial Officer & Treasurer.
  • OFS Capital Corporation is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company.

Prospect Capital Corporation Announces New 6.50% Series A3 and M3 for Current Non-Traded Preferred Stock Offering

Retrieved on: 
Friday, October 7, 2022

NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect, our, or we) announced today that Prospect has added new 6.50% Series A3 and M3 Preferred Stock to our ongoing offering of up to $1.5 billion of non-traded preferred stock (the Offering), which is being raised in the private wealth, registered investment advisor, and institutional channels.

Key Points: 
  • NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect, our, or we) announced today that Prospect has added new 6.50% Series A3 and M3 Preferred Stock to our ongoing offering of up to $1.5 billion of non-traded preferred stock (the Offering), which is being raised in the private wealth, registered investment advisor, and institutional channels.
  • Prospect is a leading issuer of non-traded preferred stock, with investors especially appreciating our non-traded preferred stock downside protection and stable returns in the current challenging macroeconomic environment.
  • Preferred Capital Securities LLC (PCS) is a securities broker dealer and the dealer manager for the ongoing Offering of the Series A3 and M3 Preferred Stock.
  • Prospect Capital Corporation is a business development company that focuses on lending to and investing in private businesses.

AIM Vaccine, a Major Player in the Chinese Vaccine Industry Successfully Listed on the Main Board of SEHK

Retrieved on: 
Thursday, October 6, 2022

The debut of AIM Vaccine's stock price was very outstanding on 6 October.

Key Points: 
  • The debut of AIM Vaccine's stock price was very outstanding on 6 October.
  • ICBC International Capital Limited is Joint Bookrunner, ICBC International Securities Limited and Livermore Holdings Limited are the Joint Lead Managers.
  • The Company said that the listing of AIM Vaccine in Hong Kong marks a key milestone and unfolds a new chapter in the Company's development.
  • Looking ahead, AIM Vaccine will continue to strive to access to quality industry resources to expand and optimize its business.

Quhuo Announces Appointment of a New Director

Retrieved on: 
Friday, September 23, 2022

BEIJING, Sept. 23, 2022 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading tech-enabled workforce operational solution platform in China, today announced the appointment of Ms. Wenying Lyuas a director to its board of directors (the "Board"), effectiveSeptember 23, 2022.

Key Points: 
  • BEIJING, Sept. 23, 2022 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading tech-enabled workforce operational solution platform in China, today announced the appointment of Ms. Wenying Lyuas a director to its board of directors (the "Board"), effectiveSeptember 23, 2022.
  • Ms. Lyucurrently serves as the Head of the Strategic Investment Management Department of Baidu, a leading AI company with a strong Internet foundation.
  • Leslie Yu, Chairman and Chief Executive Officer of Quhuo, on behalf of the Board and management, said, "We are delighted and honored to welcome Ms. Lyu to our Board.
  • Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company") is a leading workforce operational solutions platform in China.

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

Retrieved on: 
Friday, September 23, 2022

According to CIC, AIM Vaccine is the only China-based vaccine player that has all five proven human vaccine platform technologies worldwide, namely bacterial vaccine technologies, viral vaccine technologies, genetically engineered vaccine technologies, combination vaccine technologies and mRNA vaccine technologies, with at least one approved product or one vaccine candidate at CTA or clinical stages under each platform.

Key Points: 
  • According to CIC, AIM Vaccine is the only China-based vaccine player that has all five proven human vaccine platform technologies worldwide, namely bacterial vaccine technologies, viral vaccine technologies, genetically engineered vaccine technologies, combination vaccine technologies and mRNA vaccine technologies, with at least one approved product or one vaccine candidate at CTA or clinical stages under each platform.
  • AIM Vaccine currently commercializes eight vaccine products against six disease areas, of which the HBV vaccines and human rabies vaccine are its market-leading key commercialized vaccine products.
  • AIM Vaccine acquired Rong'an Bio, AIM Honesty, AIM Kanghuai and AIM Weixin between 2015 and 2017, together with their vaccine products against human rabies, HBV, HAV, mumps and HFRS.
  • AIM Vaccine has leading scientists joining or collaborating with AIM Vaccine to support the Group's vaccine development and manufacturing.

InnoCare Completes Initial Public Offering on the STAR Market of the Shanghai Stock Exchange in China

Retrieved on: 
Wednesday, September 21, 2022

InnoCare will use the net proceeds from the STAR Offering to fund its drug research and development, drug R&D platform upgrade, marketing network upgrade, information technology upgrade and working capital projects.

Key Points: 
  • InnoCare will use the net proceeds from the STAR Offering to fund its drug research and development, drug R&D platform upgrade, marketing network upgrade, information technology upgrade and working capital projects.
  • China International Capital Corporation Limited acted as a sponsor and a joint bookrunner for the STAR Offering.
  • Goldman Sachs Gao Hua Securities Company Limited, J.P. Morgan Securities (China) Company Limited and Yuekai Securities Corporation Limited acted as joint bookrunners for the STAR Offering.
  • Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare said: "It is another key milestone in InnoCares development to get listed on the STAR market.